CD40LG and breast carcinoma: GpM has also been reported to enhance NK cell activity in breast cancer patients [100], and improve the immune function of cancer patients after chemotherapy, as demonstrated by increased T lymphocyte transformation rate and decreased IgG and IgM levels [101].